Search company, investor...

Founded Year

2006

Stage

Debt - II | Alive

Total Raised

$1.64M

Last Raised

$710K | 11 yrs ago

About Real Imaging

Real Imaging develops imaging solutions for breast cancer detection which is both accurate and patient-friendly. Its proprietary technology increases correct detection rates and decreases the number of false diagnoses for women of all ages around the globe. The company was founded in 2006 and is based in Lod, Israel.

Headquarters Location

POB 1145 Airport City

Lod, 70100,

Israel

972(3)9720602

Loading...

Loading...

Real Imaging Patents

Real Imaging has filed 22 patents.

The 3 most popular patent topics include:

  • automotive technologies
  • autonomous cars
  • advanced driver assistance systems
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/1/2021

10/17/2023

Autonomous cars, Google services, Automotive technologies, Robotics, Advanced driver assistance systems

Grant

Application Date

7/1/2021

Grant Date

10/17/2023

Title

Related Topics

Autonomous cars, Google services, Automotive technologies, Robotics, Advanced driver assistance systems

Status

Grant

Real Imaging Frequently Asked Questions (FAQ)

  • When was Real Imaging founded?

    Real Imaging was founded in 2006.

  • Where is Real Imaging's headquarters?

    Real Imaging's headquarters is located at POB 1145 Airport City, Lod.

  • What is Real Imaging's latest funding round?

    Real Imaging's latest funding round is Debt - II.

  • How much did Real Imaging raise?

    Real Imaging raised a total of $1.64M.

  • Who are the investors of Real Imaging?

    Investors of Real Imaging include Reuben Brothers and Previz Ventures.

  • Who are Real Imaging's competitors?

    Competitors of Real Imaging include Redlen Technologies, Seno Medical, Micrima, Orison, U-Systems and 7 more.

Loading...

Compare Real Imaging to Competitors

M
Microwave Imaging System Technologies (MIST)

Microwave Imaging Systems Technology was founded in 1995 by Dr. Keith Paulsen and Dr. Paul Meaney of the Thayer School of Engineering and has developed a microwave-based, breast imaging system which aims to provide high-contrast images for breast cancer diagnostics. Per the company, the NIH has invested more than $6 million to develop and demonstrate the MIST system for tumor imaging. The company reports that testing on more than 150 patients has shown excellent detection of breast tumors.

F
FMI Medical Systems

FMI Medical Systems specializes in the development and design of high-end medical imaging equipment within the healthcare technology sector. The company's main offerings include computed tomography (CT) systems and positron emission tomography/computed tomography (PET/CT) systems, which are used for advanced medical diagnostics. FMI primarily serves the healthcare industry, providing imaging solutions for clinical and molecular applications. It is based in Akron, Ohio.

S
Seno Medical

Seno Medical is a medical imaging company. It develops and markets optoacoustic imaging technology for cancer diagnosis. It offers Imagio, a breast imaging system that combines laser optics and ultrasound technology to provide fused functional and anatomical breast imaging in real-time. It was founded in 2005 and is based in San Antonio, Texas.

O
Orison

Orison Corporation was founded to design, manufacture and market a ultrasound technology platform for early breast cancer detection and diagnosis. Orison's technology aims to utilize Full Field Digital Ultrasound (FDDU) as an enabler that aims to allow the radiologist, for a time, to view breast tissue in a three dimensional environment. The outcome is earlier detection of breast cancer prior to metastasis, resulting in greater five-year survival rates and decreased treatment costs.

M
Medispectra

MediSpectra, Inc. is a medical device company developing optical detection technology for enhanced accuracy and real-time results in the detection of cancer and other human tissue abnormalities. The technology is based on multimodal optical interrogation of tissue with light. Specifically, a combination of native fluorescence and white light backscatter spectroscopies are coupled with video imaging methods to more accurately detect tissue abnormalities. nnThe company's first product, the LUMA Cervical Imaging System, was designed and developed to improve the detection of high-grade pre-cancerous cervical abnormalities that have the potential of becoming invasive cancer. The LUMA product is intended for use as an adjunct to colposcopy in identifying high grade disease (CIN 2/3+) in patients referred to colposcopy with an ASCUS, LSIL or HSIL+ cervical cytology test result. n

Micrima Logo
Micrima

Micrima develops a system to improve the detection of breast cancer. The imaging system captures three-dimensional (3D) images through the use of harmless radio waves. The safe, low-cost system enables women of all ages to be screened for breast cancer in GP surgeries, or alternative high street locations, with results that are now comparable with traditional X-ray mammograms. It was founded in 2006 and is based in Bristol, United Kingdom.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.